Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Why AirSculpt Technologies Shares Are Trading Lower By 20%; Here Are 31 Stocks Moving Premarket

Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.7% to $3.93 in pre-market trading after the company reported a $5 million share repurchase program.

Benzinga

US Mega Techs Rally. Know What The Most Accurate Analysts Say Before Investing

US mega-cap tech stocks recorded sharp gains on Thursday following the release of inflation data for the month of October. Consumer price index increased 0.4% for the month and 7.7% year-over-year, recording its lowest annual rise since January and compared to the 8.2% annual rate in the previous month.

Benzinga

$10 Million Bet On Rain Therapeutics? Check Out These 4 Stocks Insiders Are Buying

Although US stocks closed sharply higher on Thursday, there were a few notable insider trades.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Nasdaq, S&P 500 Futures Build On Inflation-Data Momentum But Analyst Warn 'Desperately Craved' Rally May Not Sustain — Key Stocks To Watch Today

Trading in the U.S. index futures points to the buying momentum extending into the final session of the week. The market may turn to the University Of Michigan's consumer sentiment report for trading cues, although profit-taking could take some sheen off the rally.

Benzinga

Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday

Gainers

Benzinga

Amazon, Apple, Tesla And Other Big Gainers From Thursday

U.S. stocks closed higher on Thursday, with the Dow Jones jumping more than 1,200 points. Here is the list of some big stocks recording gains in the previous session.

Benzinga

Alibaba Jumps 7%, Nio Surges 13%: Hang Seng Breaches 17,000-mark For 1st Time Since Mid-October

Hong Kong stocks rose on Friday, with the benchmark Hang Seng opening over 5% higher, as softer-than-expected inflation in the U.S. sparked optimism among investors and traders that price rises may have peaked out.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Christmas Forever? This Rapper Says She Can't Change Her Twitter Name Due To Musk's New $8 Blue Check Mark

If you’ve ever wanted to change your name and be known as someone else, social media might be a place to start. A change on Twitter could have people second-guessing name changes, as they may end up being permanent, as one celebrity found out.

Benzinga

Check Out What Whales Are Doing With LCID

A whale with a lot of money to spend has taken a noticeably bearish stance on Lucid Gr. Looking at options history for Lucid Gr (NASDAQ:LCID) we detected 16 strange trades.

Benzinga

Nasdaq Surges 600 Points; Gold Gains 2%

U.S. stocks traded sharply higher midway through trading , with the Nasdaq Composite gaining 600 points on Thursday.

Benzinga

Rivian Heads In The Right Direction: Anaysts Lower Price Targets, Remain Cautiously Optimistic

Electric vehicle Rivian Automotive (NASDAQ: RIVN) recently shared updates on production on the heels of its third-quarter financial results.

Benzinga

Cathie Wood Swoops In On Weak Tesla: Expect A Bullish Break From This Pattern

Tesla Inc. (NASDAQ: TSLA) opened about 7% higher on Thursday after plunging the same amount on Wednesday, to reach a new two-year low of $177.59.

Benzinga

Dow Jumps Over 700 Points; US Inflation Rate Falls In October

U.S. stocks traded sharply higher this morning , following the release of inflation data on Thursday.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022

Upgrades

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Jazz Pharmaceuticals Announces Q3 2022 Financial Results, Raises Total Revenue Guidance

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced its financial results late Wednesday for the third quarter of 2022 and raised the mid-point of 2022 total revenue guidance.

Benzinga

Troubled FTX Faces SEC Probe And 'Urgently Needs' $8B To Avoid Bankruptcy, NIO Posts Wider Q3 Loss, AstraZeneca Ditches US Application Submission For COVID-19 Shot: Top Stories Thursday, Nov. 11

Bloomberg

Benzinga

Clever Leaves Q3 Revenue Declines 18% YoY, Provides Outlook

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW) Q3 2022 revenue was $3.3 million, a 18% decrease compared to $4.0 million in Q3 2021.

Benzinga

Around $5 Million Bet On This Financial Services Stock? Check Out 4 Stocks Insiders Are Buying

Although US stocks closed lower on Wednesday, there were a few notable insider trades.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why Cano Health Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 59% to $0.1619 in pre-market trading after dipping 40% on Wednesday. Fast Radius recently filed voluntary petitions for relief under Chapter 11.

Benzinga

Motorola Solutions, Domino's Pizza And 2 Other Stocks Insiders Are Selling

The Nasdaq Composite dropped over 250 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Nasdaq, S&P 500 Futures Jump As October Inflation Cools Off — Tesla, Rivian, Apple, AstraZeneca In Focus

The U.S.

Benzinga

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday

Gainers

Benzinga

Earnings Scheduled For November 10, 2022

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.

Benzinga

Alibaba Down 3%, Nio Plunges 9%: Hang Seng Opens In Red As All Eyes Turn to US Inflation Data Release

Hong Kong stocks opened weaker on Thursday, with the benchmark Hang Seng losing 1.84%, as investors eyed Thursday’s inflation data from the U.S.

Benzinga

Canopy Growth: Analyst Maintains Price Target Of $3.30, Stays Neutral After Q3 Results

Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED) recently reported its financial results for the third quarter that ended September 30, 2022 (&ldquo

1 … 273 274 275 276

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.